Human glioma cells induce hyperexcitability in cortical networks
Open Access
Abstract
Summary: Purpose: Patients with gliomas frequently present with seizures, but the factors associated with seizure development are still poorly understood. In this study, we assessed peritumoral synaptic network activity in a glioma animal model and tested the contribution of aberrant glutamate release from gliomas on glioma‐associated epileptic network activity.Methods: In vitro brain slices were made from glioma‐implanted mice. Using extracellular field recordings, we analyzed peritumoral epileptiform activity induced by Mg2+‐free medium in slices from tumor‐bearing animals and sham‐operated controls. We assessed the effect of sulfasalazine (SAS), a blocker of system and glutamate release, on spontaneous and evoked activity in tumor‐associated slices.Key Findings: Tumor‐associated cortical networks were hyperexcitable. The onset latency of Mg2+‐free–induced epileptiform activity was significantly shorter in tumor‐bearing slices, and the incidence of Mg2+‐free–induced ictal‐like events was higher. Block of glutamate release from system decreased the response area of evoked activity and completely blocked Mg2+‐free–induced ictal‐like, but not interictal‐like events.Significance: Control of seizures in patients with gliomas is an essential component of clinical management; therefore, understanding the origin of seizures is vital. This work provides evidence that peritumoral synaptic network activity is disrupted by tumor masses resulting in network excitability. We show that blocking glutamate release via system with SAS, a drug already approved by the U.S. Food and Drug Administration (FDA), can inhibit Mg2+‐free–induced ictal‐like epileptiform events similar to other chemicals used to decrease seizure activity. We, therefore, suggest that further studies should consider SAS a promising agent to aid in the treatment of seizures associated with gliomas.Keywords
This publication has 55 references indexed in Scilit:
- Glutamate release by primary brain tumors induces epileptic activityNature Medicine, 2011
- Epilepsy and brain tumorsCurrent Opinion in Oncology, 2010
- Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κBJournal of Neurochemistry, 2009
- Epilepsy and other factors in the prognosis of gliomasActa Neurologica Scandinavica, 2009
- Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiationJournal of Neurochemistry, 2008
- Molecular Targets for Antiepileptic Drug DevelopmentNeurotherapeutics, 2007
- Effects of Potassium Concentration on Firing Patterns of Low‐Calcium Epileptiform Activity in Anesthetized Rat Hippocampus: Inducing of Persistent Spike ActivityEpilepsia, 2006
- Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imagingNMR in Biomedicine, 2003
- On the Structure of Ictal Events in VitroEpilepsia, 1996
- The relationship between interictal and ictal paroxysms in an in vitro model of focal hippocampal epilepsyAnnals of Neurology, 1988